Statement: fgfr2 fusion positive is an indication that expression of a fusion containing sequences from fgfr2 has been detected in a sample. the primary trial participants recieve less than 300mg/m^2 doses of Pralatrexate.
Primary_evidence: INTERVENTION 1:    Pralatrexate   Study drug 190 mg/m^2 for 2 to 4 weeks.